Japan Tissue Engineering Co., Ltd. (JP:7774) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Japan Tissue Engineering Co., Ltd. reports a decline in financial performance in the first quarter of FY2024 with net sales down by 33.2% and a net loss of 211 million yen, contrasting the positive figures from the previous year. The company’s total assets decreased slightly, while the equity ratio improved to 88.5%. No dividends were paid in FY2023, and the same is forecasted for FY2024.
For further insights into JP:7774 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money